These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28267398)

  • 41. [Pylorus-preserving pancreatic head resection: a new standard for tumors].
    Glanemann M; Bahra M; Neuhaus P
    Chirurg; 2008 Dec; 79(12):1107-14. PubMed ID: 18998104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Onset symptoms and tumor locations as prognostic factors of pancreatic cancer.
    Watanabe I; Sasaki S; Konishi M; Nakagohri T; Inoue K; Oda T; Kinoshita T
    Pancreas; 2004 Mar; 28(2):160-5. PubMed ID: 15028948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraductal Oncocytic Papillary Neoplasms of the Pancreas.
    Kallen ME; Naini BV
    Arch Pathol Lab Med; 2016 Sep; 140(9):992-6. PubMed ID: 27575268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The first experience of a central pancreatic resection, using laparoscopic access].
    Kopchak KV; Duvalko OV; Andronik SV; Romaniv IaV; Khomiak AI
    Klin Khir; 2014 Apr; (4):62-3. PubMed ID: 25097983
    [No Abstract]   [Full Text] [Related]  

  • 45. [Surgical treatment of pancreatic carcinoma: problems and recent advances].
    Yang YM; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):401-403. PubMed ID: 27938571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Location, location, location: precursors and prognoses for pancreatic cancer.
    Hingorani SR
    Gastroenterology; 2007 Jul; 133(1):345-50. PubMed ID: 17631154
    [No Abstract]   [Full Text] [Related]  

  • 47. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
    Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixed ductal-endocrine carcinoma of pancreas.
    Ahmad Z; Mumtaz S; Fatima S; Qureshi A
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intraductal papillary-mucinous neoplasm of the pancreas].
    Yamaguchi K; Watanabe M; Nakamura M; Konomi H; Tanaka M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():52-9. PubMed ID: 16457221
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients.
    Shin SH; Kim SC; Song KB; Hwang DW; Lee JH; Park KM; Lee YJ
    Surgery; 2018 Sep; 164(3):432-442. PubMed ID: 29884479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma?
    Santi I; Brandt A; Hemminki K
    Ann Surg Oncol; 2011 Jan; 18(1):300-1. PubMed ID: 20589435
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytological features of pancreatic intraductal tubulopapillary neoplasm and an unexpected immunohistochemical profile.
    Zhao L; Hart J; Xiao SY; Antic T
    Pathology; 2014 Dec; 46(7):662-5. PubMed ID: 25393265
    [No Abstract]   [Full Text] [Related]  

  • 54. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.
    Ishida J; Toyama H; Matsumoto I; Asari S; Goto T; Terai S; Nanno Y; Yamashita A; Mizumoto T; Ueda Y; Kido M; Ajiki T; Fukumoto T; Ku Y
    Pancreatology; 2016; 16(4):615-20. PubMed ID: 27237099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pancreatic incidentalomas. Correct assessment and therapy].
    Hopt U; Keck T
    Chirurg; 2007 Aug; 78(8):713-20. PubMed ID: 17628760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sarcomatoid carcinoma of the pancreas: A case report and review of the literature.
    Xie Y; Xiang Y; Zhang D; Yao X; Sheng J; Yang Y; Zhang X
    Mol Med Rep; 2018 Nov; 18(5):4716-4724. PubMed ID: 30221744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer.
    Duan L; Hu XQ; Feng DY; Lei SY; Hu GH
    Asian J Surg; 2013 Jan; 36(1):7-12. PubMed ID: 23270819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma.
    Yamada M; Hirabayashi K; Kawanishi A; Hadano A; Takanashi Y; Izumi H; Kawaguchi Y; Mine T; Nakamura N; Nakagohri T
    Surg Today; 2018 May; 48(5):510-516. PubMed ID: 29256146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modern management of pancreatic carcinoma.
    Goldstein D; Carroll S; Apte M; Keogh G
    Intern Med J; 2004 Aug; 34(8):475-81. PubMed ID: 15317546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.